The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

About Us

What are the benefits & risks of avoiding high-dose chemotherapy?

Jacqueline Garcia

December 7, 2020

During the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, Know AML spoke to Jacqueline Garcia, Dana-Farber Cancer Institute, Boston, US, about the benefits and risks of avoiding high-dose chemotherapy. Garcia explains that high-dose chemotherapy is not the best therapy for all patients. She also gives an overview of the alternative therapies available for patients who are unable to receive high-dose chemotherapy.